Lubiprostone
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2D2-25-R-0022
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a solicitation for a national requirements contract for Lubiprostone Capsules, specifically 24MCG and 8MCG formulations in 60 count bottles. This will be an unrestricted and fully competitive acquisition utilizing FAR Part 12 commercial item procedures, with all sources eligible to submit proposals for agency consideration. The resulting firm-fixed price requirements contract will feature a one-year base period with four one-year option periods and will establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs. The contract will operate under FAR 52.216-21 Requirements provisions to supply pharmaceutical preparations as needed by these federal agencies. The projected solicitation release date is September 2025, though DLA reserves the right to issue the solicitation before or after this projected timeframe. Interested parties should contact Jeremy Brown at (445) 737-5419 or jeremy.brown@dla.mil for questions and are advised to establish automated notifications for solicitation updates through the official procurement websites.
This opportunity carries no set-aside designation and will be available to all qualified contractors in an open competition. No current incumbent contractors or potential award values are specified in the pre-solicitation notice. The procurement focuses on two specific dosage strengths of Lubiprostone capsules packaged in standardized 60-count bottles for pharmaceutical distribution. Annual usage estimates will be detailed in the Schedule of Supplies section when the formal solicitation is released. The contract structure spans a maximum of five years total performance period when including all option years. The solicitation will be posted on both the DLA Bid Board System (DIBBS) and Sam.Gov for contractor access and proposal submission.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lubiprostone Capsules. Procurement details follow.
Lubiprostone 24MCG Capsules and Lubiprostone 8 MCG Capsules in 60 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Lubiprostone | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Latanoprost Ophthalmic Solution (VA-27-00006027) | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity